InvestorsHub Logo

thefamilyman

09/30/20 12:08 PM

#3700 RE: buckysherm #3699

That was a missed opportunity and very disappointing. I thought this new guy was going to be more cognizant of PR and shareholder communications.

Buckysherm said,

They talked about Covid affecting the NASH trial, but nothing about research for GRMD02 treating Covid.